0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam
ide
0LI is a Ligand Of Interest in 6EG9 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6EG9_0LI_A_501 | 60% | 8% | 0.16 | 0.949 | 2.75 | 1.74 | 11 | 8 | 0 | 0 | 100% | 1 |
| 6EG9_0LI_B_501 | 58% | 8% | 0.177 | 0.962 | 2.73 | 1.78 | 11 | 13 | 2 | 0 | 100% | 1 |
| 6P3D_0LI_A_1001 | 86% | 15% | 0.098 | 0.973 | 2.03 | 1.66 | 6 | 11 | 0 | 0 | 100% | 1 |
| 7WF5_0LI_A_601 | 83% | 24% | 0.085 | 0.948 | 1.54 | 1.46 | 7 | 5 | 1 | 0 | 100% | 1 |
| 8S17_0LI_A_1001 | 83% | 56% | 0.081 | 0.943 | 0.65 | 0.91 | - | 2 | 1 | 0 | 100% | 1 |
| 9P6A_0LI_A_701 | 82% | 30% | 0.097 | 0.956 | 0.66 | 2.01 | - | 12 | 2 | 0 | 100% | 1 |
| 4U0I_0LI_A_1001 | 81% | 14% | 0.103 | 0.96 | 2.57 | 1.26 | 18 | 5 | 2 | 0 | 100% | 1 |
